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Abstract
Background: The medical needs of older people are growing because the proportion of the older population is increasing
and disease boundaries are widening. This study describes the distribution and clustering of 15 common clinical disorders
requiring medical treatment or supervision in a representative British cohort approaching retirement, and how health
tracked across adulthood.
Methods and Findings: The data come from a cohort of 2661 men and women, 84% of the target sample, followed since
birth in England, Scotland and Wales in 1946, and assessed at 60–64 years for: cardio and cerebro-vascular disease,
hypertension, raised cholesterol, renal impairment, diabetes, obesity, hypothyroidism, hyperthyroidism, anaemia, respiratory
disease, liver disease, psychiatric problems, cancers, atrial fibrillation on ECG and osteoporosis. We calculated the
proportions disorder-free, with one or more disorders, and the level of undiagnosed disorders; and how these disorders
cluster into latent classes and relate to health assessed at 36 years. Participants had, on average, two disorders (range 0–9);
only 15% were disorder-free. The commonest disorders were hypertension (54.3%, 95% CI 51.8%–56.7%), obesity (31.1%,
28.8%–33.5%), raised cholesterol (25.6%, 23.1–28.26%), and diabetes or impaired fasting glucose (25.0%, 22.6–27.5%). A
cluster of one in five individuals had a high probability of cardio-metabolic disorders and were twice as likely than others to
have been in the poorest health at 36 years. The main limitations are that the native born sample is entirely white, and a
combination of clinical assessments and self reports were used.
Conclusions: Most British people reaching retirement already have clinical disorders requiring medical supervision.
Widening disease definitions and the move from a disease-based to a risk-based medical model will increase pressure on
health services. The promotion of healthy ageing should start earlier in life and consider the individual’s ability to adapt to
and self manage changes in health.
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Introduction
There is a longstanding and ongoing debate about the widening
boundaries of disease and the costs and benefits of the
medicalisation of health [1–5]. This debate is particularly relevant
for the very old where multiple morbidity and polypharmacy are
common and complicate treatment planning [6], and where
medical problems may be overlooked or ignored [2]. It is also
relevant for the early detection of disease at younger ages; for
example, recent recommendations to screen everyone over 45
years for risk factors for cardiovascular disease [7] or prescribe
statins or some form of ‘polypill’ for all those over 55 years old [8]
would increase the proportion of the population with a disorder
label and requiring regular medical supervision.
This debate needs to be informed about the current health
status and treatment of older people. For the oldest old, in
England, the Newcastle 85+ cohort [9] provides a description of
their health status and treatment, and shows that nobody in this
sample was disease free. National health surveys [10–12] also
provide relevant information about the older population but they
typically focus on different aspects of health in different years; and
because they consist of a different population sample each year, it
is impossible to estimate the extent of multiple morbidity.
Moreover there is no way of defining in these surveys who is
‘well’ in the sense of being disease free.
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In a national sample of the British population reaching
retirement age, we investigate the extent of common clinical
disorders, defined as an impairment of body system or structure
for which there is evidence or a consensus for medical
intervention, in terms of active monitoring or treatment. The
data come from the Medical Research Council (MRC) National
Survey of Health and Development (NSHD), a birth cohort study
of men and women born in 1946 and followed ever since [13,14].
The generation that this cohort represents is important to study,
being the first of the post World War II baby boom, and
benefitting from increased longevity compared with earlier
cohorts. This generation will contribute to the growing proportion
of the population aged 65 years and over, which is expected to rise
in the UK by 32% from 11.8 million in 2008 to reach 15.6 million
by 2033 [15]. The health of the baby boomers as they age will
dominate the work of the health and social care systems for the
next three decades, not only in the UK but in all Western
developed nations.
In this cohort aged 60–64 years, we describe: the proportions
with, and sex differences in, fifteen common clinical disorders of
later life; the extent to which these clinical disorders are already
diagnosed and/or treated; how these disorders are distributed and
relate to current self reported health; and how these disorders
cluster into latent classes and relate to health status previously
assessed at age 36 years.
Methods
Ethics statement
The study protocol received ethical approval from the Central
Manchester Research Ethics Committee for data collection taking
place in Manchester, Birmingham, Cardiff and London. Ethical
permission was given by the Scotland A Research Ethics
Committee for the data collection taking place in Edinburgh.
Written informed consent was obtained from the study member at
each stage of data collection.
Participants
The MRC NSHD is a socially stratified sample of 5362
singleton children born in one week in March 1946 in England,
Scotland and Wales [14]. From an initial maternity survey in 1946
[16], the sample consisted of all single births to married women
with husbands in non-manual and agricultural employment and
one in four of all comparable births to women with husbands in
manual employment. Of the 5362 original study members, the
study team was still in contact with 3163 (59%) at age 60–64 years;
718 (13.4%) had died, 594 (11.1%) had previously withdrawn from
the study, 567 (10.6%) lived abroad and 320 (5.9%) had been
untraceable for more than ten years.
Study members received postal questionnaires between 2007
and 2008 and were invited for clinic visits between October 2007
and February 2011. If study members were unable or unwilling to
come to one of the six Clinical Research Facilities (Edinburgh,
Manchester, Cardiff, Birmingham, UCLH London or St Thomas’
London) they were offered a slightly less comprehensive exami-
nation carried out in their own home by a trained nurse.
Of the 3163 people in the target sample, information was
obtained from the postal questionnaire and/or visits from 2661
(84%). Of these, 2462 people completed the postal questionnaire
and 2229 had a visit, of whom 1690 attended a clinic and 539 had
a home visit.
Self-reported disorders
For stroke, diabetes, cancer, angina, myocardial infarction (MI)
and thyroid disease we went back to the first occasion on which
participants were asked if they had ever had a doctor diagnosis of
these conditions. These reports were updated at subsequent data
collections. In 1989, participants were first asked if they had ever
been told by a doctor that they had had a stroke, diabetes or
cancer; in 1999 a similar question referred to angina, MI and
thyroid disease; and in the most recent data collection questions on
coronary artery bypass graft, angioplasty or stent were included.
Cancers were also picked up from registrations on the NHS
Information Centre Registry.
Symptom scales
At age 60–64 years participants completed postal versions of the
MRC Chronic Bronchitis [17] and the Rose Angina and
Intermittent Claudication [18] questionnaires. The General
Health Questionnaire (GHQ-28) [19] which asks about affective
symptoms was self completed during the clinic or home visit.
Prescribed medications
As part of the postal questionnaire, participants were asked to
list all their prescribed medications, and the reasons why these
were prescribed. These were checked by the nurses and used to
help define some disorders (see below).
Clinical assessments
Full details of the research protocol can be found elsewhere [14]
but brief descriptions are given below. Those visited by a nurse at
home received the same assessment except for the scans.
Cardiovascular assessment. Two measures of systolic and
diastolic blood pressure were taken with an OMROM 705 with
the participant seated, with the second reading used in this
analysis. Participants visiting the clinic also had a 12 lead
electrocardiogram recorded (Burdick Eclipse 850i). The output
was sent by modem to the ECG Core Laboratory at the University
of Glasgow for reporting.
DXA bone scans. Bone density scans were performed in the
lumbar spine (L1–4) and proximal femur (femoral neck, total hip)
using Hologic QDR 4500 Discovery scanners (Hologic Inc.,
Bedford MA, USA) according to standard protocols developed by
Prof. J. Adams. Scans were sent to the central core laboratory in
the University of Manchester for analysis.
Blood sample. Participants were asked to fast from
22.00 hours on the night before the visit, and the majority of
blood samples were collected between 08.00 and 09.00 hours the
following day. Samples were processed on site according to
standardised protocols. Full blood counts were undertaken at the
local hospital on the day of the visit. Aliquots were dispatched to
Addenbrooke’s Hospital Cambridge for HbA1c to be measured.
The remaining aliquots were stored at 280uC and couriered
monthly, on dry ice, to the MRC Human Nutrition Research
(HNR) laboratory in Cambridge. Serum lipids, fasting blood
glucose, liver function tests, and serum creatinine were measured
at HNR, and thyroid function tests at Addenbrooke’s Hospital.
Serum total cholesterol, HDL cholesterol, triglycerides, glucose,
and all liver function test parameters were measured colorimet-
rically on a Siemens Dimension Xpand analyser. LDL cholesterol
was calculated from total cholesterol. HbA1c was analysed using
the TOSOH G7 HPLC system. TSH and Free T4 were analysed
using the Siemens Centaur Automated Immunoassay System. Free
T3 was analysed using the Perkin Elmer AutoDELFIA Automated
Immunoassay System until June 2009 and thereafter using the
Clinical Disorders at Retirement Age
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Siemens Centaur. Serum creatinine measurements were carried
out using the Jaffe method.
Defining the clinical disorders
We assessed 15 clinical disorders expected in people of this age
group: cardio/cerebro-vascular disease, hypertension, raised
cholesterol, renal impairment, diabetes, obesity, hypothyroidism,
hyperthyroidism, anaemia, respiratory disease, liver disease,
psychiatric problems, cancers, ECG abnormalities, and osteopo-
rosis.
Clinical disorder status was derived from one or more of: a self–
report of a doctor diagnosis of disease in response to a specific
question; being positive on a validated scale for the disorder; a
clinical assessment; currently receiving prescribed treatment for
the disorder; or cancer registrations. The data sources and
definitions for each clinical disorder are given in Table 1 [17–
27]. For some conditions (hypertension, raised cholesterol, renal
impairment, diabetes, obesity, hypothyroidism, and hyperthyroid-
ism) two levels of disorder were defined, level 1 where intervention
is required irrespective of other information and level 2 where the
type of intervention may depend on other information. For
example, whether or not to treat a person with a raised cholesterol
level depends on the overall 10 year risk of a significant event.
Covariates
Health status at 36 years. Cohort members had previously
been identified as being in the best of health (10%), intermediate
(65%) or worst of health (25%) at age 36 years on the basis of
measured blood pressure, lung function and body weight, self
reported health problems and disability, and recent hospital
admission [28].
Self-reported health status at 60–64 years. At age 60–64
years participants were asked to rate their current health on a
5 point scale from excellent to poor.
Statistical methods
The proportion with each clinical disorder was calculated as the
number of participants meeting the relevant definition (see Table 1)
divided by the number of participants with valid data for that
measure. Where more than one measure was used in the definition
of a disorder (for example total:HDL cholesterol ratio and
reported statin/fibrate use for level 1 raised cholesterol), the
sample was restricted to those with valid data for all relevant
measures. The proportions were weighted to account for the social
stratification in the original sample. Unweighted proportions were
also calculated for comparison.
Undiagnosed disease. The number of participants who had
diabetes, osteoporosis, hypertension, and thyroid disorders on
examination, but who had not reported a doctor diagnosis of that
condition or who were not on treatment for that specific disorder
was divided by the total number of participants, to give the
proportion of the total sample with undiagnosed disease. The
proportion of those undiagnosed within the sample who had each
of these disorders was also calculated. Social class-weighted results
are presented, but unweighted results were produced for
comparison.
Distribution and clustering of clinical disorders. For
each participant for whom status on all the 15 disorders was
defined, the number of identified clinical disorders was counted;
this was initially restricted to level 1 disorders, then repeated to
include those with level 2 disorders also. The number of disorders
per participant was compared between sexes, and by self-rated
health using a chi-squared test, grouping those with five or more
clinical disorders together. This analysis was then repeated
excluding the two disorders (osteoporosis and ECG abnormalities)
that depended on the clinic visit for ascertainment. We assessed
whether the number of disorders varied according to whether
participants had a clinic or home visit, and by current self reported
health status. Both weighted and unweighted analyses were again
conducted.
To explore further the clustering of level 1 clinical disorders,
latent class analysis (LCA) was performed on the level 1 clinical
disorder variables. Latent class analysis is a multivariable
regression model that describes the relationships between a set
of observed dependent variables (‘latent class indicators’), in this
case the clinical disorders, and an unobserved categorical latent
variable, each level of which is referred to as a ‘latent class’. For
dichotomous latent class indicators, as in the present application,
the relationships are described by a set of logistic regression
equations [29]. LCA assumes conditional independence of
variables within each latent class. The objective is to identify the
latent class indicators that best distinguish between classes and to
categorise people into their most likely classes given their observed
responses [30]. We used a variety of different tools to decide how
many classes were required as no single approach is commonly
accepted: the Lo-Mendell-Rubin adjusted likelihood ratio test
(LRT), the bootstrap LRT, and three information criteria –
Akaike’s Information Criterion (AIC), Schwarz’s Bayesian Infor-
mation Criterion (BIC), and sample size-adjusted BIC (aBIC). The
entropy, relative sizes, and meaningful interpretation of the latent
classes were also considered. LCA was performed on complete
cases only, then repeated using all study members who contributed
data on at least one clinical disorder using full information
maximum likelihood (FIML) under the assumption of missing at
random for comparison [31]. LCA was conducted using Mplus
version 6 [32].
The relationship between the latent classes and health status at
36 years was investigated using logistic regression of each latent
variable on health status, weighted by the LCA posterior class
membership probabilities.
Results
2657 survey members contributed to the analysis for one or
more clinical disorders. Of these, 1104 (41.6%) belonged to the
manual social class strata as defined at the initial sampling in 1946.
This compares to 2370 (44.2%) of the 5362 study members
originally in the cohort.
The commonest disorders were level 1 or level 2 hypertension
(54%), obesity (31%), raised cholesterol (27%), and diabetes or
impaired fasting glucose (26%). Other disorders affecting at least
one in ten people were psychiatric disorders (19%), chronic
respiratory disease (12%), cancers (11%), osteoporosis (11%),
cardiovascular disease (11%) and renal impairment (10%);
hypothyroidism (7%) and liver disease (5%) were less common.
There was strong evidence for sex differences in many of the
conditions examined. The others showed weak evidence (inter-
mittent claudication, level 2 hyperthyroidism and cancers) or no
evidence (anaemia, chronic respiratory disease, level 2 obesity and
level 2 renal impairment); the number with level 1 renal
impairment was too low to detect a sex difference. Hypertension,
raised cholesterol, diabetes, cardiovascular problems, ECG
abnormalities and abnormal liver function were more common
in men, and psychiatric problems, thyroid disease, osteoporosis,
and level 1 i.e. morbid obesity were more common in women
(Table 2). The unweighted prevalences were similar for most
clinical disorders, but slightly lower for several (results not shown).
Clinical Disorders at Retirement Age
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This would be expected if the disorders were more prevalent in the
manual social class, of which a smaller fraction were sampled.
Previously undiagnosed disorders
Table 3 shows the proportions with undiagnosed hypertension,
diabetes, thyroid disease, and osteoporosis in the responding
sample. Nine percent of the sample had undiagnosed untreated
osteoporosis (79% of those with osteoporosis), 6% undiagnosed
hypertension (15% of those with hypertension), 3% undiagnosed
diabetes (39% of those with diabetes), and ,1% undetected
thyroid disease (8% of those with thyroid disease). Undiagnosed
hypertension and diabetes were commoner in men. Undiagnosed
osteoporosis was commoner in women in the full sample; however,
within the group with osteoporosis, men were more likely to be
undiagnosed (90%) than women (74%). There were no evidence of
sex differences in undiagnosed thyroid disorders. The results from
the unweighted analysis were very similar to those in the weighted
analysis (results not shown).
Distribution of clinical disorders and relationship to
current self reported health
Table 4 shows the distribution for the number of level 1 clinical
disorders for those with information on all 15 or 13 clinical
disorders. Thirty percent of the participants were free of all of the
15 level 1 disorders. The results on the larger sample, excluding
the conditions only defined at the clinic visit (osteoporosis and
ECG abnormalities), were similar, but slightly more participants
(33%) were disorder free. In both cases the median number of level
1 disorders was 1 (range 0–8), and there was no evidence of sex
difference in the number of disorders.
Table 5 shows the number of level 1 and level 2 clinical
disorders in those with information on all 15 or 13 clinical
disorders. Only 15% were free of either a level 1 or level 2
Table 1. Clinical disorders, level 2 and level 1, with data sources and definitions.
Clinical disorder Level 2/level 1 Constituent sub-disorders/definition
Level 1 CVD Level 1 i) Angina (self-report of doctor diagnosed angina or self-reported by Rose chest pain questionnaire [18];
ii) CABG (self-report of CABG);
iii) Angioplasty/stent (self-report of angioplasty or stent);
iv) MI (self-report of doctor diagnosed MI);
v) Stroke (self-report of doctor diagnosed stroke); or
vi) Intermittent claudication (self-reported by Rose intermittent claudication questionnaire [18].
Hypertension Level 1 Current SBP$160 mmHg or current DBP$100 mmHg, or reported being on anti-hypertensive medication.
Level 2 Current SBP$140 mmHg or current DBP$90 mmHg but were not included in the ‘level 1 hypertension’ group.
Raised cholesterol Level 1 Total:HDL cholesterol ratio $6.0 mmol/l or reported being on statins or fibrates.
Level 2 Chance of developing a cardiovascular disease within the next 10 years$20% according to the Framingham risk score
[20] but not included in the ‘level 1 raised cholesterol’ group. Risk score was calculated using current age, LDL and HDL
cholesterol, current SBP and DBP, current smoking status (self-reported by direct questions), and ‘level 1 diabetes’ (see
below).
Renal impairment Level 1 eGFR,30 ml/min/1.73 m2 [21]. eGFR calculated from serum creatinine using the MDRD formula [22].
Level 2 30#eGFR,60 ml/min/1.73 m2 or dipstick proteinuria$+ [22].
Diabetes Level 1 FBG$7 mmol/l (restricted to study members who reported fasting appropriately), self-report of doctor diagnosed
diabetes, or reported being on diabetes medication.
Level 2 6.0.FBG,7 mmol/l (restricted to study members who reported fasting appropriately) [23].
Obesity Level 1 BMI$40 kg/m2 [20]. BMI calculated as weight (m)/height (kg)2 [24].
Level 2 30 kg/m2#BMI],40 kg/m2 [24].
Hypothyroidism Level 1 Self-report of doctor diagnosed hypothyroidism, TSH.5.5 mU/l and free T4,10.0 pmol/l (modified from Wilson 2006
[25]), or reported being on thyroxine.
Level 2 TSH.5.5 mU/l and 10.0#free T4#19.8 pmol/l (modified from Wilson 2006 [25]).
Hyperthyroidism Level 1 Self-report of doctor diagnosed hyperthyroidism, TSH,0.4 mU/l and free T3.7.5 pmol/l (modified from Wilson 2006
[25]), or reported being on medication.
Level 2 TSH,0.4 mU/l and 3.0#free T3#7.5 pmol/l and 10.0#free T4#19.8 pmol/l (modified from Wilson 2006 [25]).
Anemia Level 1 Haemoglobin ,13 g/dl (males) or haemoglobin ,12 g/dl (females) [26].
Respiratory disease Level 1 Chronic bronchitis symptoms (MRC chronic bronchitis questionnaire [17]) or reported being on medication.
Liver disease Level 1 Albumin ,25 g/l, bilirubin .100 mmol/l, alkaline phosphatase .300 IU/l, alanine transaminase .300 IU/l, aspartate
transaminase .300 IU/l, or gamma glutamyl transferase .100 IU/l.
Psychiatric problems Level 1 GHQ ‘caseness’ ($5 items ‘worse than usual’ or ‘much worse than usual’) [19].
Cancers Level 1 Self-report of doctor diagnosed cancer or cancer reported to the cancer registry.
ECG abnormalities Level 1 Atrial fibrillation, atrial flutter or definite MI of any age.
Osteoporosis Level 1 Bone density t-score by DXA scan #2.5 at spine, femoral neck, or hip [27].
CVD, cardiovascular disease; CABG, coronary artery bypass graft; MI, myocardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density
lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate; MDRD, modification of diet in renal impairment; FBG, fasting blood glucose; TSH,
thyrotrophin-stimulating hormone; T4, thyroxine; T3, triiodothyronine; MRC, Medical Research Council; GHQ, General Health Questionnaire; ECG, electrocardiogram;
DXA, dual-emission X-ray absorptiometry.
doi:10.1371/journal.pone.0044857.t001
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disorders when 15 clinical disorders were considered, and 16%
were disorder free when 13 clinical disorders were considered. In
both cases the median number of level 2 or level 1 disorders was 2
(range 0 to 9). Women were somewhat more likely to be disorder
free.
The distributions of the number of clinical disorders per study
member were broadly similar in the unweighted analysis, though a
slightly greater proportion of study members were disorder-free
(results not shown). Again, this would be expected if disorders were
more prevalent in the manual social class.
Those who had a home visit were less likely to be free from
clinical disorders than those who had a clinic visit (23.3% v.
34.0%, p= 0.02 for level 1 clinical disorders).
In the total responding sample, 13% of participants described
their health as excellent, 40% as very good, 32% as good, 13% as
fair, and 2% as poor. These ratings were strongly associated with
the number of level 1 and level 2 clinical disorders reported
(p,0.001). For example, considering all 15 clinical disorders, 77%
of those with no level 1 or 2 clinical disorders rated their health as
excellent or very good and 2% rated it as fair or poor; but only
31% of those with 5 or more level 1 or 2 disorders rated their
health as excellent or very good and 40% rated it as fair or poor.
Around 50% of study members with cardiovascular disease or
morbid obesity rated their health as fair or poor. These figures
were essentially unchanged in the unweighted analysis.
Clustering of clinical disorders and relationship to health
status at 36 years
Level 1 renal impairment was excluded from the LCA as the
prevalence was too low. The remaining 14 clinical disorders meant
that there were 16384 possible patterns of clinical disorders within
Table 2. Number and percent with level 1 and level 2 clinical disorders in men and women 60–64 years in the MRC National
Survey of Health and Development.
Males Females Total
Clinical disorder
Level 2/
level 1 n/N % (95% CI)A n/N % (95% CI)A n/N % (95% CI)A
P for diff
between
sexes
Level 1 CVD
Angina Level 1 97/1164 9.2 (7.3, 11.4) 60/1263 5.2 (3.9, 6.9) 157/2427 7.1 (5.9, 8.5) 0.002
CABG Level 1 22/1136 2.3 (1.4, 3.6) 3/1209 0.3 (0.1, 1.2) 25/2345 1.3 (0.8, 2.0) 0.001
Angioplasty/stent Level 1 40/1127 3.7 (2.6, 5.3) 13/1205 1.3 (0.7, 2.4) 53/2332 2.5 (1.8, 3.4) 0.002
MI Level 1 59/1146 5.8 (4.3, 7.7) 15/1215 1.7 (0.9, 2.9) 74/2361 3.7 (2.8, 4.7) ,0.001
Stroke Level 1 34/1181 3.1 (2.1, 4.6) 21/1268 2.1 (1.3, 3.4) 55/2449 2.6 (1.9, 3.5) 0.21
Intermittent claudication Level 1 13/1152 1.4 (0.8, 2.6) 6/1235 0.4 (0.2, 1.1) 19/2387 0.9 (0.5, 1.5) 0.03
Any level 1 CVD Level 1 133/1048 13.8 (11.5, 16.6) 71/1093 7.5 (5.8, 9.7) 204/2141 10.6 (9.1, 12.3) ,0.001
Hypertension Level 1 407/1061 41.2 (37.6, 44.8) 348/1147 33.0 (29.8, 36.3) 755/2208 36.8 (34.4, 39.3) 0.001
Level 2 225/1061 20.2 (17.5, 23.2) 188/1147 14.9 (12.6, 17.5) 413/2208 17.4 (15.6, 19.4) 0.005
Raised cholesterol Level 1 269/960 28.0 (24.7, 31.5) 176/1024 18.2 (15.5, 21.3) 445/1984 22.9 (20.7, 25.2) ,0.001
Level 2 63/785 8.9 (6.7, 11.6) 5/838 0.4 (0.1, 1.3) 68/1623 4.5 (3.4, 5.9) ,0.001
Renal impairment Level 1 2/913 0.2 (0.0, 1.2) 0/942 0.0 (NA, NA) 2/1855 0.1 (0.0, 0.6) NA
Level 2 95/895 11.4 (9.1, 14.2) 78/932 9.4 (7.3, 12.0) 173/1827 10.4 (8.8, 12.3) 0.25
Diabetes Level 1 101/834 12.8 (10.3, 15.9) 66/907 7.4 (5.6, 9.7) 167/1741 9.9 (8.4, 11.8) 0.002
Level 2 180/917 20.5 (17.5, 23.9) 113/982 11.9 (9.7, 14.6) 293/1899 16.0 (14.1, 18.1) ,0.001
Obesity Level 1 10/1061 0.7 (0.3, 1.5) 31/1158 3.0 (2.0, 4.5) 41/2219 1.9 (1.3, 2.7) ,0.001
Level 2 290/1061 29.3 (26.1, 32.7) 320/1158 29.1 (26.0, 32.3) 610/2219 29.2 (26.9, 31.5) 0.93
Hypothyroidism Level 1 20/903 1.8 (1.0, 3.0) 107/969 10.9 (8.7, 13.5) 127/1872 6.5 (5.3, 8.0) ,0.001
Level 2 18/1000 1.5 (0.9, 2.7) 67/1063 6.4 (4.8,8.4) 85/2063 4.1 (3.2, 5.2) ,0.001
Hyperthyroidism Level 1 6/903 0.6 (0.2, 1.6) 22/968 2.7 (1.7, 4.3) 28/1871 1.7 (1.1, 2.6) 0.003
Level 2 7/1000 0.6 (0.2, 1.5) 17/1062 1.5 (0.8, 2.6) 24/2062 1.0 (0.6, 1.7) 0.09
Anemia Level 1 45/999 3.8 (2.7, 5.5) 48/1063 5.1 (3.7, 7.0) 93/2062 4.5 (3.6, 5.7) 0.23
Respiratory disease Level 1 140/1132 12.6 (10.4, 15.1) 140/1223 12.2 (10.2, 14.6) 280/2355 12.4 (10.9, 14.1) 0.84
Liver disease Level 1 74/1002 7.3 (5.6, 9.5) 37/1059 3.3 (2.2, 4.8) 111/2061 5.2 (4.2, 6.5) 0.001
Psychiatric problems Level 1 137/1047 13.5 (11.2, 16.2) 250/1136 23.3 (20.4, 26.4) 387/2183 18.7 (16.8, 20.7) ,0.001
Cancers Level 1 108/1169 9.6 (7.8, 11.9) 164/1270 12.5 (10.5, 14.8) 272/2439 11.1 (9.7, 12.7) 0.06
ECG abnormalities Level 1 47/785 6.2 (4.5, 8.6) 14/846 2.1 (1.1, 3.7) 61B/1631 4.1 (3.0, 5.4) 0.001
Osteoporosis Level 1 50/780 7.3 (5.3, 10.0) 129/853 14.0 (11.5, 17.0) 179/1633 10.9 (9.2, 12.8) ,0.001
AWeighted according to original social class-stratified sampling. CVD, cardiovascular disease; CABG, coronary artery bypass graft; IC, intermittent claudication; MI,
myocardial infarction; ECG, electrocardiogram.
BOf whom 31(2.3%) had atrial fibrillation.
doi:10.1371/journal.pone.0044857.t002
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the dataset. There was strong evidence that LCA models in which
parameters were allowed to differ between males and females
provided a better fit to the data than a model which combined
both sexes. For both males and females a two class model provided
the best fit to the data. Figures 1 and 2 show the latent classes of
clinical disorders for males and females respectively using
standardised probabilities, which are calculated by dividing the
probability of each clinical disorder in each latent class by the
observed proportion of study members with that disorder in the
sample. For both males and females there was a smaller latent class
(n = 77 for men and n=112 for women) in which participants had
a high probability of cardio-metabolic disorders (Figure 1a and
2a). The remaining larger latent class for men (n= 436) and
women (n= 428) had a generally low probability of disorders
(Figure 1b and 2b). As this larger cluster included participants with
no disorders, the analysis was repeated excluding them. This gave
essentially the same result, distinguishing those with a high
probability of cardio-metabolic disorders from others. Repeating
the LCA using all study members who contributed data on at least
one clinical disorder using FIML increased the number of study
members contributing to the analysis to 1283 men and 1374
women. Two latent classes were again required for both men and
women, and the probabilities of each clinical disorder within each
latent class were very similar to those in the complete case analysis
(results not shown). However, the classes were not as clearly
separated (lower entropy) due to the inclusion of study members
with reduced information.
In both males and females there was evidence of a trend in the
relationship between the latent classes at 60–64 years and health
status at age 36 years, with those in the worst health at age 36
more likely to be in the cardio-metabolic latent class almost thirty
years later. Of those in the worst of health at 36 years, 25.5% of
men and 30.9% of women were in the cardio-metabolic latent
class at 60–4 years, whereas this was only true for only 13.2% of
men and 14.6% of women in the best of health almost thirty years
earlier (p = 0.02 and p= 0.003 respectively). When using the latent
classes derived under FIML the magnitude of the associations was
very similar (results not shown).
Discussion
Key findings
In this survey of common clinical disorders in the first wave of
British baby boomers at 60–64 years, we found that most had
clinical disorders even though the majority described their general
health as good, or better. These disorders were widely spread
across the population, with only one in six people being free of all
the disorders considered i.e. not requiring any medical interven-
Table 3. Diagnosed and undiagnosed level 1 clinical disorders.
n/N (%A)
Males Females Total
Clinical disorder Diagnosed Undiagnosed Diagnosed Undiagnosed Diagnosed Undiagnosed
P for diff in
undiagnosed
between sexes
Hypertension 331/1061 (32.5) 76/1061 (8.7) 309/1147 (29.5) 39/1147 (3.5) 640/2208 (30.9) 115/2208 (5.9) ,0.001
Diabetes 58/834 (8.0) 43/834 (4.8) 43/907 (5.2) 23/907 (2.2) 101/1741 (6.5) 66/1741 (3.4) 0.01
Hypothyroidism 19/903 (1.6) 1/903 (0.2) 99/969 (10.2) 8/969 (0.6) 118/1872 (6.1) 9/1872 (0.4) 0.26
Hyperthyriodism 5/903 (0.6) 1/903 (0.1) 19/968 (2.4) 3/968 (0.3) 24/1871 (1.5) 4/1871 (0.2) 0.12
Osteoporosis 5/780 (0.5) 45/780 (6.8) 33/853 (3.7) 96/853 (10.3) 38/1633 (2.2) 141/1633 (8.6) 0.04
AWeighted according to original social class-stratified sampling.
doi:10.1371/journal.pone.0044857.t003
Table 4. Number (percent) of level 1 clinical disorders per study member.
n (%A)
All clinical disorders (max. 15)B Excluding osteoporosis and ECG abnormalities (max. 13)C
Number of clinical
disorders Males Females Total Males Females Total
0 146 (26.3) 171 (32.4) 317 (29.5) 194 (30.8) 222 (34.2) 416 (32.6)
1 178 (34.4) 162 (29.6) 340 (31.8) 206 (32.0) 198 (31.6) 404 (31.8)
2 84 (18.2) 114 (19.6) 198 (18.9) 96 (16.1) 115 (17.6) 211 (16.9)
3 63 (12.8) 53 (10.5) 116 (11.6) 72 (12.5) 58 (10.0) 130 (11.2)
4 28 (5.2) 24 (4.4) 52 (4.8) 31 (5.5) 22 (3.8) 53 (4.6)
5+ 14 (3.3) 15 (3.6) 29 (3.5) 16 (3.0) 13 (2.7) 29 (2.8)
Total 513 539 1052 615 628 1243
AWeighted according to original social class-stratified sampling.
BRange: 0–8; median: 1; P value for diff between sexes = 0.46.
CRange: 0–8; median: 1; P value for diff between sexes = 0.60.
doi:10.1371/journal.pone.0044857.t004
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tion; this distribution was strongly related to self reported health.
We identified a latent class of cardio-metabolic disorders, covering
one in five of the population; this class was more likely to have had
poor health as young adults.
Strengths and limitations of the study
As with all longitudinal studies NSHD has suffered from
attrition. However, this is a large, national cohort that remains
reasonably representative of the British born population. The
NSHD study population is however all white, and therefore our
findings cannot be extrapolated to the non-White British
population. Non-White people make up 9% of the current
population of England and Wales but they generally have a
younger age profile, and only 5% of the population 60–64 years
are non-White [33].
Some of our disorders are defined only on self–report of a
doctor’s diagnosis of disease. However, self-reports are generally
found to be reasonably accurate when compared with medical
records in cases of definite diagnoses [34,35]. In the NSHD we
sent questionnaires to GPs asking them to confirm self reports of
chronic disease; for diabetes we found over 90% agreement [36].
We only measured blood pressure on one occasion so we may have
overestimated the amount of previously undiagnosed hyperten-
sion, since in practice a diagnosis of hypertension is based on at
least two readings taken at different times.
Rare disorders or common disorders in which confirmatory
clinical assessments were not possible, and treatment is non-
specific e.g. arthritis, were not included. Hence this study
estimated the extent of common clinical disorders rather than
the full extent of health problems in this cohort at retirement age.
Although our analysis of the clustering of clinical disorders
within study members was presented for complete cases only,
obtaining very similar results using all study members who
contributed data on at least one clinical disorder suggested that
Table 5. Number (percent) of level 1-level 2 clinical disorders per study member.
n (%A)
All clinical disorders (max. 15)B Excluding osteoporosis and ECG abnormalities (max. 13)C
Number of
clinical
disorders Males Females Total Males Females Total
0 69 (11.3) 92 (17.7) 161 (14.7) 91 (13.8) 117 (18.2) 208 (16.1)
1 116 (22.5) 128 (23.4) 244 (23.0) 148 (23.9) 160 (26.7) 308 (25.3)
2 108 (24.1) 128 (24.8) 236 (24.4) 119 (21.8) 150 (24.8) 269 (23.3)
3 89 (18.0) 83 (16.4) 172 (17.2) 103 (17.1) 90 (15.5) 193 (16.3)
4 61 (12.6) 50 (9.6) 111 (11.0) 64 (12.1) 52 (8.0) 116 (10.0)
5+ 50 (11.5) 39 (8.1) 89 (9.7) 60 (11.3) 35 (6.8) 95 (9.0)
Total 493 520 1013 585 604 1199
AWeighted according to original social class-stratified sampling.
BRange: 0–9; median: 2; P value for diff between sexes = 0.13.
CRange: 0–9; median: 2; P value for diff between sexes = 0.03.
doi:10.1371/journal.pone.0044857.t005
Figure 1. 1a and 1b. Latent classes of level 1 clinical disorders
(excluding renalimpairment) in males (n=513). Standardised
probabilities are calculated by dividing the probability of each clinical
disorder within each latent class by the observed proportion of study
members with that disorder in the sample.
doi:10.1371/journal.pone.0044857.g001
Figure 2. 2a and 2b. Latent classes of level 1 clinical disorders
(excluding renal impairment) in females (n=540). Standardised
probabilities are calculated by dividing the probability of each clinical
disorder within each latent class by the observed proportion of study
members with that disorder in the sample.
doi:10.1371/journal.pone.0044857.g002
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significant bias was not introduced.
Comparison of our findings with other published studies
The proportions observed for cancers, diabetes, thyroid disease,
obesity and psychiatric problems were similar to those in other
studies, as were those for previously undiagnosed thyroid disorders
and diabetes [20,22,36–44]. The major difference between our
results and other reported studies was in relation to hypertension,
the NSHD population had noticeably more people with hyper-
tension than reported in HSE 2009 [37]. Our findings on renal
impairment are not directly comparable with the other UK data
[37,42] as these studies report CKD stages 3–5 (NICE 2008) [21]
which exclude people with proteinuria but eGFR.60 ml/min/
1.73 m2 from being classified as having renal impairment. In
NSHD the proportion with of CKD stages 3–5 is slightly lower
than for the other studies [37,42]. However people with
proteinuria alone do have a higher CVD and renal progression
risk [22], and the NSHD identifies this group for the first time in a
British general population. We found somewhat fewer MIs,
strokes, and better respiratory function than has been reported
in cross–sectional studies in people aged 64–69 in England [38],
but this is probably accounted for by the age difference. NSHD
women had somewhat less osteoporosis than estimated by WHO
[27]; this may be an underestimation because participants who
attended the clinics (where bone densitometry was available) had
fewer clinical disorders than the people seen at home visits.
Undetected disorders. There was a high proportion of
undetected osteoporosis in men and women. This is a condition
that is not screened for as population screening is not cost effective
[44]. National guidelines [44] do encourage case finding but this
may not be widely applied and awareness of the problem in men is
not high [45]. This may improve in the future with osteoporosis
being introduced into the Quality Outcomes Framework in 2012.
Undetected diabetes within the responding population was more
frequent than found in the English Longitudinal Study of Ageing
[39]; almost two fifths of those with diabetes had not been
previously diagnosed. There was very little undetected thyroid
disease, as found in the Birmingham Elderly Thyroid Study
(BETS) [25]. This may be explained by GP awareness of thyroid
disorders conditions and their success in case finding. The levels of
undiagnosed hypertension and diabetes should reduce once the
proposal for Vascular Screening system in the over 45 year-olds
comes on-line in general practice [7].
Multiple disorders and clustering of disorders. In the
Newcastle cohort study of those aged 85 years and older, nobody
was disorder-free. This study also included heart failure, dementia
and Parkinson’s disease but we did not, as these conditions are rare
in 65 years olds. Unlike our study, the authors found that women
had more clinical disorders than men [9].
The picture we outline here is in many ways a best case
scenario. It may be that that people born in the immediate post-
war period are healthier than earlier or later born people because
they have spent their whole lives within the post-war welfare state
and only later experienced exposure to obesogenic lifestyles. There
are a number of other conditions which we have not included, e.g.
sarcopenia and osteopenia, that are as yet not monitored or
treated but, given shifting boundaries, could easily become defined
as clinical disorders [4]. We have not followed recent proposals for
extending risk factors further back into the normal distribution
identifying ‘prehypertension’ ( SBP$120 mmHg ); impaired
fasting glycaemia as beginning at 5.6 mmol/l ; and borderline
risk of LDL as beginning at 3.6 mmol/l. In the US population
Kaplan and Ong [46] estimate that such categorization of these
three risk factors alone would result in 97% of the population
being under medical surveillance.
The study of patterns of multi-morbidity is relatively new field.
There are few studies that have examined the way conditions
cluster within groups of patients. One in the USA examined the
records of 1.3 million primary care patients cared for by the
Veterans Health Care System with two or more co morbidities
and categorized 45 health conditions [47]. They reported that
83% of their sample fell into their metabolic cluster. An Australian
study in working age adults [48] found that health conditions do
not cluster neatly into organ or body systems as has been assumed
by methods underpinning the Cumulative Index Rating Scale [49]
and they identified 6 independent clusters of disorders.
Implications
Few people are without a clinical disorder on reaching
retirement age. This highlights two sets of problems – the first is
conceptual, related to our changing definition of disease and to
current theories of ageing; and the second is pragmatic, and
concerns the workload of health services going forward.
We have increasingly moved from a diseased-based model of
medicine where doctors reacted to signs and symptoms presented
by the patient, to a more proactive risk based model in which
many clinical disorders are the end of a distribution of biological
attributes, and are detected on the basis of case finding. This move
has been driven by the success of epidemiological studies in
identifying risk factors, and demonstrating effective interventions
to reduce risk and to treat diseases early. Certainly this more
proactive approach has coincided with a marked reduction in
mortality rates for cardiovascular disease [50], although some
would argue that the relationship between the two is not causal
[51].
Individuals have different patterns of ageing. Such patterns have
been postulated as; ‘survivors’ who live with extended morbidity
due to age related disease diagnosed before old age; ‘extenders’
who live longer than expected without problems and have a
shorter period of disability before death; and ‘escapers’ who attain
very old age without disease [49,50]. As life expectancy increases
there is a debate about whether we are facing a compression of
morbidity, with people both living longer and having a longer
period of healthy life (more extenders and escapers) or an
expansion of morbidity with people living longer but having little
or no increase in healthy life (more survivors). Alternatively, we
may be facing some intermediate state involving more people
living longer but with less severe morbidity (more survivors but
with less disability). It has been proposed that ageing research
should focus on extenders and escapers, to identify factors related
to compression of morbidity and to avoid a pandemic of disability
[52,53], and not just on age-related disease.
However, our research, and that emerging from the Nether-
lands [54], suggest that only a small minority of people in Western
populations are ‘escapers’ or ‘extenders’, even by retirement age.
Data from the Longitudinal Aging Study Amsterdam do not
support the compression of morbidity scenario [54], and a study
across OECD countries shows inconsistent results [55]. Thus
ageing with clinical disorders may become the norm, and it might
better to speak in terms of health relative to others of the same age.
This situation is prompting new formulations of the meaning of
health, especially in relation to older people, which focus on the
individual’s ability to adapt and self manage physically, psycho-
logically and socially to their changing internal and external
environment [56,57].
With our changing definitions of disease and the ageing
population comes a significant load on the health services,
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especially general practice, in terms of monitoring and treatment.
Not only is general practice delivering its traditional reactive role
but it is increasingly expected to deliver the preventive care part of
the public health agenda. The effect on workload is already being
seen. Over the past decade patient consultation rates per patient in
England and Wales have increased over 40% (from 3.9 in 1995/6
to 5.5 per patient per year 2008/9) [58], and this is also being seen
in the other OECD countries [59].
The commonest conditions in this study are cardio-metabolic,
cancers and osteoporosis which share common upstream causes in
the nutritional deterioration of the nation’s diet and sedentary
behaviour. Unless we are able to tackle successfully these upstream
causes on a societal level, we will be left with treating the effects in
individuals, either monitoring and trying to change behaviour or
prescribing medications. Our demonstration that health status at
retirement is strongly associated with health status almost thirty
years earlier suggests that a high risk group could be identified that
may benefit from individual level interventions that start earlier
than middle age. The current structure of the clinical care is still
based on the disease model, and may be overwhelmed by the
demands of proactive care. The purpose of this paper is not to give
solutions to these problems, but to highlight the current position,
and emphasize that the proportion of the population ‘under the
doctor’ will only increase given an ageing population and
diagnostic creep.
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